National trends in long-term use of antidepressant medications: Results from the US National Health and Nutrition Examination Survey

Journal of Clinical Psychiatry

Volumn 75, Issue 2, 2014, Pages 169-177

  Mojtabai, Ramin ^a,b   Olfson, Mark ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Psychiatry College of Physicians and Surgeons Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG SURVEILLANCE PROGRAM; DRUG USE; ETHNIC DIFFERENCE; FEMALE; HEALTH SURVEY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH CARE; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; TREATMENT DURATION; TREND STUDY; UNITED STATES;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84896841974     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08443     Document Type: Article

References (68)

1. Mojtabai R. Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychother Psychosom. 2008;77(2):83-92. doi:10.159/01285 PubMed (Pubitemid 351172098)
2. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66(8):848-856. doi:10.101/ archgenpsychiatry.209.81 PubMed
3. Paulose-Ram R, Safran MA, Jonas BS, et al. Trends in psychotropic medication use among US adults. Pharmacoepidemiol Drug Saf. 2007;16(5):560-570. doi:10.102/pds.1367 PubMed (Pubitemid 46824278)
4. Milea D, Verpillat P, Guelfucci F, et al. Prescription patterns of antidepressants: findings from a US claims database. Curr Med Res Opin. 2010;26(6):1343-1353. doi:10.185/0307910372096 PubMed
5. Baldessarini RJ, Tondo L, Strombom IM, et al. Ecological studies of antidepressant treatment and suicidal risks. Harv Rev Psychiatry. 2007;15(4):133-145. doi:10.1080/10673207015102 PubMed (Pubitemid 47237774)
6. McManus P, Mant A, Mitchell P, et al. Use of antidepressants by general practitioners and psychiatrists in Australia. Aust N Z J Psychiatry. 2003;37(2):184-189. doi:10.1046/j.140-1614.203.0132.x PubMed (Pubitemid 36592728)
7. Helgason T, Tómasson H, Zoega T. Antidepressants and public health in Iceland: time series analysis of national data. Br J Psychiatry. 2004;184(2):157-162. doi:10.192/bjp.184.2.157 PubMed (Pubitemid 38186858)
8. Hemels ME, Koren G, Einarson TR. Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother. 2002;36(9):1375-1379. doi:10.1345/aph.1A31 PubMed (Pubitemid 34925271)
9. IMS Health. Top therapeutic classes by US dispensed prescriptions. http://www.imshealth.com/deployedfiles/ims/Global/Content/Corporate/ Press%20Room/Top-Line%20Market%20Data%20&%20Trends/2011%20Top- line%20Market%20Data/Top-Therapy-Classes-by-RX.pdf. Updated February 23, 2012. Accessed December 22, 2012.
10. IMS Health. Top 20 global therapeutic classes. http://www.imshealth.com/ deployedfiles/ims/Global/Content/Corporate/Press%20Room/Top- line%20Market%20Data/2010%20Top-line%20Market%20Data/Top-20-Global-Therapy- Classes.pdf. Updated December 2010. Accessed July22, 2013.
11. Ilyas S, Moncrieff J. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. Br J Psychiatry. 2012;200(5):393-398. doi:10.192/bjp.bp.1.104257 PubMed
12. Dasgupta A, Lawson KA. Utilization of and expenditures for selective serotonin reuptake inhibitors (SSRIs) and factors associated with change in price per-prescription of brand SSRIs in the Texas Medicaid programme (1991-2009). J Pharm Health Serv Res. 2013;4(2):105-113. doi:10.1/jphs.12010
13. Druss BG, Marcus SC, Olfson M, et al. Listening to generic Prozac: winners, losers, and sideliners. Health Aff (Millwood). 2004;23(5):210-216. doi:10.137/hlthaf.23.5.210 PubMed (Pubitemid 39303506)
14. Nielsen M, Gøtzsche P. An analysis of psychotropic drug sales. Increasing sales of selective serotonin reuptake inhibitors are closely related to number of products. Int J Risk Saf Med. 2011;23(2):125-132. PubMed
15. Mojtabai R. Americans' attitudes toward psychiatric medications: 1998-2006. Psychiatr Serv. 2009;60(8):1015-1023. doi:10.176/api.ps.60.8.1015 PubMed
16. Moore M, Yuen HM, Dunn N, et al. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ. 2009;339(2):b3999. doi:10.136/bmj.b39 PubMed
17. Lockhart P, Guthrie B. Trends in primary care antidepressant prescribing, 1995-2007: a longitudinal population database analysis. Br J Gen Pract. 2011;61(590):e565-e572. doi:10.39/bjgp1X593848 PubMed
18. Sihvo S, Wahlbeck K, McCallum A, et al. Increase in the duration of antidepressant treatment from 1994 to 2003: a nationwide population-based study from Finland. Pharmacoepidemiol Drug Saf. 2010;19(11):1186-1193. doi:10.102/pds.2017 PubMed
19. Parabiaghi A, Franchi C, Tettamanti M, et al. Antidepressants utilization among elderly in Lombardy from 2000 to 2007: dispensing trends and appropriateness. Eur J Clin Pharmacol. 2011;67(10):1077-1083. doi:10.107/s028-01-1054-z PubMed
20. Raymond CB, Morgan SG, Caetano PA. Antidepressant utilization in British Columbia from 1996 to 2004: increasing prevalence but not incidence. Psychiatr Serv. 2007;58(1):79-84. doi:10.176/api.ps.58.1.79 PubMed
21. Akincigil A, Bowblis JR, Levin C, et al. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care. 2007;45(4):363-369. doi:10.1097/01.mlr.0254574.23418.f6 PubMed
22. Busch SH, Leslie D, Rosenheck R. Measuring quality of pharmacotherapy for depression in a national health care system. Med Care. 2004;42(6):532-542. doi:10.1097/01.mlr.01280.96869.1e PubMed
23. Olfson M, Marcus SC, Tedeschi M, et al. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163(1):101-108. doi:10.176/api.ajp.163.1.101 PubMed (Pubitemid 43050110)
24. Spijker J, de Graaf R, Bijl RV, et al. Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry. 2002;181(3):208-213. doi:10.192/bjp.181.3.208 PubMed (Pubitemid 34983527)
25. Kennedy SH, Lam RW, Nutt DJ, et al. Treating Depression Effectively: Applying Clinical Guidelines. London, UK: Informa Healthcare; 2007.
26. Work Group on Major Depressive Disorder. Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition. http://www.psychiatryonline.org/guidelines.aspx. Updated November 2010. Accessed March 11, 2012.
27. Canadian Psychiatric Association. Clinical practice guidelines. Management of anxiety disorders. Can J Psychiatry. 2006;51(suppl 2):9S-91S. PubMed
28. Work Group on Panic Disorder. Practice Guideline for Treatment of Patients With Panic Disorder, Second Edition. 2009. Accessed June 30, 2013. http://psychiatryonline.org/pdfaccess.ashx?ResourceID=243182&PDFSource=6
29. Cruickshank G, Macgillivray S, Bruce D, et al. Cross-sectional survey of patients in receipt of long-term repeat prescriptions for antidepressant drugs in primary care. Ment Health Fam Med. 2008;5(2):105-109. PubMed
30. Dickinson R, Knapp P, House AO, et al. Long-term prescribing of antidepressants in the older population: a qualitative study. Br J Gen Pract. 2010;60(573):e144-e155. doi:10.39/bjgp10X483913 PubMed
31. National Center for Health Statistics. National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes.htm/. Updated July 11, 2013. Accessed December 22, 2012.
32. Mojtabai R. Antidepressant use and glycemic control. Psychopharmacology (Berl). 2013;227(3):467-477. doi:10.107/s0213-013-2972-5 PubMed
33. Boudreau DM, Daling JR, Malone KE, et al. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol. 2004;159(3):308-317. doi:10.1093/aje/kwh038 PubMed (Pubitemid 38141661)
34. Haukka J, Suvisaari J, Tuulio-Henriksson A, et al. High concordance between self-reported medication and official prescription database information. Eur J Clin Pharmacol. 2007;63(11):1069-1074. doi:10.107/s028-07-0349-6 PubMed (Pubitemid 47561801)
35. Cotterchio M, Kreiger N, Darlington G, et al. Comparison of self-reported and physician-reported antidepressant medication use. Ann Epidemiol. 1999;9(5):283-289. doi:10.1016/S1047-2797(98)072-6 PubMed (Pubitemid 29289842)
36. Sarangarm P, Young B, Rayburn W, et al. Agreement between self-report and prescription data in medical records for pregnant women. Birth Defects Res A Clin Mol Teratol. 2012;94(3):153-161. doi:10.102/bdra.28 PubMed
37. Haapea M, Miettunen J, Lindeman S, et al. Agreement between self-reported and pharmacy data on medication use in the Northern Finland 1966 Birth Cohort. Int J Methods Psychiatr Res. 2010;19(2):88-96. PubMed
38. Tisnado DM, Adams JL, Liu H, et al. What is the concordance between the medical record and patient self-report as data sources for ambulatory care? Med Care. 2006;44(2):132-140. doi:10.1097/01.mlr.0196952.15921.bf PubMed (Pubitemid 43755464)
39. Kwon A, Bungay KM, Pei Y, et al. Antidepressant use: concordance between self-report and claims records. Med Care. 2003;41(3):368-374. doi:10.1097/01.MLR.053019.79054.B6 PubMed
40. Boudreau DM, Doescher MP, Saver BG, et al. Reliability of Group Health Cooperative automated pharmacy data by drug benefit status. Pharmacoepidemiol Drug Saf. 2005;14(12):877-884. doi:10.102/pds.19 PubMed (Pubitemid 43056114)
41. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.201.01609606.x PubMed (Pubitemid 32823891)
42. Huang FY, Chung H, Kroenke K, et al. Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med. 2006;21(6):547-552. doi:10.1/j.1525-1497.206.0409.x PubMed (Pubitemid 43801481)
43. Vittinghoff E, Glidden DV, Shiboski SC, et al. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. New York, NY: Springer; 2005.
44. Patten SC. The duration of major depressive episodes in the Canadian general population. Chronic Dis Can. 2001;22(1):6-11. PubMed
45. Monroe SM, Harkness KL. Is depression a chronic mental illness? Psychol Med. 2012;42(5):899-902. doi:10.1017/S03291710206 PubMed
46. Burton C, Maxwell M. Depression as chronic disease. Br J Gen Pract. 2007; 57(540):582. PubMed
47. Tylee A, Walters P. We need a chronic disease management model for depression in primary care. Br J Gen Pract. 2007;57(538):348-350. PubMed
48. Yonkers KA, Bruce SE, Dyck IR, et al. Chronicity, relapse, and illness - course of panic disorder, social phobia, and generalized anxiety disorder: findings in men and women from 8 years of follow-up. Depress Anxiety. 2003;17(3):173-179. doi:10.102/da.10106 PubMed (Pubitemid 36644715)
49. Mark TL, Levit KR, Buck JA. Datapoints: psychotropic drug prescriptions by medical specialty. Psychiatr Serv. 2009;60(9):1167. doi:10.176/api.ps.60.9. 167 PubMed
50. Pincus HA, Houtsinger JK, Bachman J, et al. Depression in primary care: bringing behavioral health care into the mainstream. Health Aff (Millwood). 2005;24(1):271-276. doi:10.137/hlthaf.24.1.271 PubMed (Pubitemid 40169794)
51. .Wagner EH, Austin BT, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20(6):64-78. doi:10.137/hlthaf.20.6.64 PubMed (Pubitemid 33707442)
52. .Woltmann E, Grogan-Kaylor A, Perron B, et al. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatry. 2012;169(8):790-804. doi:10.176/api.ajp.2012. 1616 PubMed
53. Roy-Byrne PP, Wagner AW, Schraufnagel TJ. Understanding and treating panic disorder in the primary care setting. J Clin Psychiatry. 2005;66(suppl 4):16-22. PubMed (Pubitemid 40637721)
54. Rubio JM, Markowitz JC, Alegría A, et al. Epidemiology of chronic and nonchronic major depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Depress Anxiety. 2011;28(8):622-631. doi:10.102/da.20864 PubMed
55. Fava GA, Offidani E. The mechanisms of tolerance in antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(7):1593-1602. doi:10.1016/j.pnpbp.2010.07.026 PubMed
56. Middleton DJ, Cameron IM, Reid IC. Continuity and monitoring of antidepressant therapy in a primary care setting. Qual Prim Care. 2011;19(2):109-113. PubMed
57. Mojtabai R, Olfson M. Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Aff (Millwood). 2011;30(8):1434-1442. doi:10.137/hlthaf.2010.1024 PubMed
58. Mojtabai R, Olfson M. National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the National Comorbidity Survey Replication. J Clin Psychiatry. 2008;69(7):1064-1074. doi:10.408/JCP.v69n0704 PubMed (Pubitemid 352031588)
59. Alegría M, Chatterji P, Wells K, et al. Disparity in depression treatment among racial and ethnic minority populations in the United States. Psychiatr Serv. 2008;59(11):1264-1272. doi:10.176/api.ps.59.1.1264 PubMed
60. González HM, Vega WA, Williams DR, et al. Depression care in the United States: too little for too few. Arch Gen Psychiatry. 2010;67(1):37-46. doi:10.101/archgenpsychiatry.209.168 PubMed
61. Jackson JL, Shimeall W, Sessums L, et al. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ. 2010;341(1):c5222. doi:10.136/bmj.c52 PubMed
62. Rahimi R, Nikfar S, Rezaie A, et al. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol. 2009;15(13):1548-1553. doi:10.3748/wjg.15.1548 PubMed
63. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;(4):CD005454. PubMed
64. Serna C, Cruz I, Galván L, et al. Evolution of the prevalence and incidence of consumption of antidepressants in a Spanish region (2002-2007). Ment Health Fam Med. 2010;7(1):9-15. PubMed
65. Mark TL. For what diagnoses are psychotropic medications being prescribed? a nationally representative survey of physicians. CNS Drugs. 2010;24(4):319-326. doi:10.2165/153120-0-0 PubMed
66. Samples H, Mojtabai R. Antidepressant use in the European Union: perceived indications and patterns. Psychiatr Serv. 2013;64(3):208. doi:10.176/api.ps.0562012 PubMed
67. Mojtabai R. The public health impact of antidepressants: an instrumental variable analysis. J Affect Disord. 2011;134(1-3):188-197. doi:10.1016/j.jad. 201.05.037 PubMed
68. Croghan TW, Melfi CA, Dobrez DG, et al. Effect of mental health specialty care on antidepressant length of therapy. Med Care. 1999;37(suppl Lilly):AS20-AS23. doi:10.1097/05650-190401-04 PubMed